4-Thiazolecarboxylicacid,2-Amino-5-Chloro-,Ethylester(9Ci)

4-Thiazolecarboxylicacid,2-Amino-5-Chloro-,Ethylester(9Ci)


    • Product Name 4-Thiazolecarboxylicacid,2-Amino-5-Chloro-,Ethylester(9Ci)
    • Alias Ethyl 2-amino-5-chlorothiazole-4-carboxylate
    • Einecs 419-170-3
    • Mininmum Order 1g
    • Factory Site West Ujimqin Banner, Xilingol League, Inner Mongolia, China
    • Price Inquiry sales9@bouling-chem.com
    • Manufacturer Bouling Chemical Co., Limited
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    259179

    Chemical Formula C6H7ClN2O2S
    Molar Mass 206.65 g/mol
    Appearance Solid (predicted)
    Boiling Point Unknown
    Melting Point Unknown
    Solubility In Water Poorly soluble (predicted)
    Logp 1.63 (predicted)
    Density Unknown
    Pka Unknown
    Flash Point Unknown

    As an accredited 4-Thiazolecarboxylicacid,2-Amino-5-Chloro-,Ethylester(9Ci) factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing 100g of 2 - Amino - 5 - chloro - 4 - thiazolecarboxylic acid ethyl ester (9Ci) in sealed chemical - grade packaging.
    Shipping Shipping of 2 - Amino - 5 - chloro - 4 - thiazolecarboxylic acid ethyl ester (9Ci) requires strict compliance with chemical transport regulations. It should be properly packaged to prevent leakage, and shipped via carriers experienced in handling such chemicals.
    Storage Store “4 - Thiazolecarboxylic acid, 2 - Amino - 5 - Chloro -, Ethyl ester (9Ci)” in a cool, dry, well - ventilated area away from heat sources and ignition sources. Keep it in a tightly closed container, preferably in a storage cabinet dedicated to chemicals. Avoid contact with incompatible substances like strong oxidizers, acids, or bases to prevent reactions and ensure safety.
    Application of 4-Thiazolecarboxylicacid,2-Amino-5-Chloro-,Ethylester(9Ci)
    The bulk manufacturing route to cefixime—a third-generation oral cephalosporin with activity against penicillin-resistant *Streptococcus pneumoniae*—relies on a precisely halogenated 2-aminothiazole-4-carboxylate ester as the acylating agent precursor. Ethyl 2-amino-5-chloro-thiazole-4-carboxylate is first hydrolysed to the corresponding carboxylic acid in a solution of isopropanol and deionized water (1.2:1 v/v) using 1.05 molar equivalents of sodium hydroxide at 20–25 °C. After pH adjustment to 3.8–4.2 with concentrated HCl, the free acid is filtered, washed to conductivity < 10 µS/cm, and dried under vacuum (≤ 50 °C, 10 mbar) until LOD < 0.5%. The drying endpoint is determined by a Mettler-Toledo Halogen Moisture Analyzer against the USP <731> requirement. The dried 2-amino-5-chlorothiazole-4-carboxylic acid is then suspended in dichloromethane (10 volumes) and reacted with methoxyacetyl chloride (1.08 eq) in the presence of N-methylmorpholine (1.15 eq) at −5 to 0 °C. The acylation is complete within 4 h as monitored by in-process HPLC (C18, 254 nm, retention time shift from 4.2 min to 7.8 min). The resulting (Z)-2-(2-amino-5-chlorothiazol-4-yl)-2-methoxyimino acetic acid is converted to the 2-mercaptobenzothiazole active ester using dicyclohexylcarbodiimide (1.0 eq) and a catalytic quantity of 4-dimethylaminopyridine (0.05 eq) in tetrahydrofuran at 0–5 °C. Dicyclohexylurea is removed by filtration through a 0.5 µm PTFE membrane behind an in-line bag filter. The filtrate is concentrated under reduced pressure and the active ester is crystallized from isopropyl alcohol–n-heptane (3:7 v/v) at −10 °C over 8 h with a seed load of 0.1% w/w. The crystalline solid is collected on a Nutsche filter under nitrogen blanket and dried in a double-cone rotary dryer at 40 °C for 12 h. Final purity by HPLC (area percentage) is ≥ 99.0%, with single impurities capped at ≤ 0.10%. Residual solvent testing per USP <467> Procedure A shows dichloromethane < 60 ppm, THF < 720 ppm, isopropanol < 5000 ppm, and n-heptane < 5000 ppm. The active ester is then coupled with 7-amino-3-vinyl-3-cephem-4-carboxylic acid (7-AVCA) in aqueous acetone under GMP conditions (ICH Q7 § 7.3) to deliver cefixime after deprotection. Every batch released for cephalosporin synthesis must be accompanied by a transmissible spongiform encephalopathy (TSE)/BSE declaration, residual elemental impurity data mapped to ICH Q3D Option 2A, and a nitrosamine risk evaluation per EMA/409815/2020.

    What Differentiates the 5-Chloro Substituent from Non-Halogenated Analogues During Cefdinir Side-Chain Construction?

    Cefdinir, another oral expanded-spectrum cephalosporin, requires a different stereoelectronic environment at the 4-position of the 2-aminothiazole ring compared to cefixime. When ethyl 2-amino-5-chlorothiazole-4-carboxylate replaces ethyl 2-aminothiazole-4-carboxylate, the electron-withdrawing chlorine preserves the acidity of the α-hydrogen on the methoxyimino group while reducing the nucleophilic character of the thiazole nitrogen, which minimizes undesired ring-opening side reactions during active ester formation. In a typical cefdinir process, the same hydrolysed intermediate—2-amino-5-chlorothiazole-4-carboxylic acid—undergoes methoximation with a slightly excess of methoxylamine hydrochloride (1.02 eq) in water–methanol (4:1 v/v) at 55–60 °C for 6 h. The (Z)-isomer precipitates upon cooling to 5 °C; the Z/E ratio must be ≥ 98:2 as verified by 1H NMR (δ of methoxy singlet at 3.95 ppm vs. 3.88 ppm for the E-isomer). The isolated acid is then activated toward aminolysis by forming the S-(2-benzothiazolyl) ester as described earlier, but with an additional requirement of strictly anhydrous conditions (< 100 ppm water by Karl Fischer) to suppress premature hydrolysis. The coupling partner is 7-amino-3-cephem-4-carboxylic acid protected at C-3 with an appropriate leaving group; the reaction is conducted in acetone–water (2.5:1 v/v) with triethylamine (1.5 eq) at −15 to −10 °C using a jacketed stainless-steel reactor with external circulation chiller capable of removing ≥ 250 W/L of exothermic heat. After coupling, pH is adjusted to 4.5 with diluted sulfuric acid, and the crude cefdinir is precipitated, filtered, and further purified through a macroporous resin column (Diaion HP-20). Quality control of the side-chain intermediate for cefdinir manufacturing includes a specific test for chlorinated dioxins and furans (WHO-PCDD/F-TEQ < 0.1 ng/kg) because of the halogen position, as well as compliance with the Ph.Eur. monograph 07/2022:2606 and JP XIX specifications for ceftizoxime-related substances profiling.Granulation and tableting of the final cefdinir formulation frequently encounter compression problems when residual methoxylamine is not adequately purged; therefore, a supplementary washing step using purified water at 40 °C for 30 min is inserted before drying, reducing methoxylamine carryover to ≤ 0.05% w/w. The dihydrate form of cefdinir crystallizes in a specific monoclonic lattice only when the aminothiazole side-chain was constructed from the 5-chloro precursor, as verified by powder X-ray diffractometry (PXRD) against reference pattern supplied in the JP. Deviation outside ±0.2° 2θ at the 12.5° and 22.1° peaks triggers a batch rejection on the GMP floor.Veterinary cephalosporins such as cefquinome demand a manufacturing chain that meets simultaneously the stringent human pharmaceutical GMP framework and the separate residue monitoring criteria of Commission Regulation (EU) No 37/2010. The ethyl 2-amino-5-chlorothiazole-4-carboxylate building block enters the synthesis of the cefquinome side-chain through an identical hydrolysis–methoxyimination sequence, but the activation chemistry diverges because the final coupling must accommodate the unique aminothiazolyl-(Z)-2-methoxyiminoacetyl side chain attached to the 7-amino-cepheme nucleus with a C-3 1-methyl-2-pyrrolidinone substituent. Industrial production runs at 150–300 kg per batch in glass-lined reactors (Pfaudler AE series, 5000 L) equipped with retreat-curve impellers operating at 85–95 rpm to ensure uniform solids suspension during the methoxyimination slurry. The 2-amino-5-chlorothiazole-4-carboxylic acid is dissolved in acetonitrile–water (1:1 v/v) with 1.10 eq of sodium bicarbonate before dropwise addition of methoxylamine hydrochloride. The critical process parameter for colour stability (absorbance at 420 nm, ≤ 0.15 AU for a 5% w/v solution) is the rate of oxygen exclusion—nitrogen sparging at 2.0 Nm³/h is maintained throughout the 6-hour reaction. After acidification and phase separation, the organic layer is dried over sodium sulfate, filtered, and concentrated in a falling-film evaporator at 45 °C jacket temperature. The methoxyimino acid is converted to its p-nitrobenzyl ester for temporary protection during the final assembly, a step that introduces a parallel quality control check for p-nitrobenzyl alcohol (≤ 0.15% w/w) by UV-HPLC. Residual API in husbandry environments is regulated through MRL enforcement under EU 37/2010 (cefquinome marker residue: sum of cefquinome and its desacetyl metabolite at 20 µg/kg in bovine milk), which places a direct burden on the intermediate supplier to demonstrate that no residue-carrying contamination (e.g., cross-contact of non-veterinary-dedicated equipment) enters the supply chain. Cleaning validation follows EMA CVMP/VICH GL46 with a maximum allowable carryover of 0.06% of the therapeutic daily dose, verified by liquid chromatography–tandem mass spectrometry with a limit of quantification of 0.1 µg/L in rinse water.The ring-structure of ethyl 2-amino-5-chlorothiazole-4-carboxylate can be elaborated into disperse azo dyes for polyester fibres, where the chlorine atom enhances both lightfastness and washfastness by increasing the electron deficiency of the diazo component. A typical diazotization protocol charges 0.25 mol of the hydrolysed intermediate (2-amino-5-chlorothiazole-4-carboxylic acid) into 180 mL of 85% phosphoric acid at 0–5 °C. Sodium nitrite (0.26 mol) is added portionwise over 45 min, and the diazonium solution is stirred for an additional 60 min until a positive nitrite test with starch-iodide paper persists. The diazonium salt is then coupled with a selected N,N-dialkylaniline coupling component dissolved in 10% sulfuric acid containing 0.05% w/w of a nonionic dispersing agent (e.g., fatty alcohol ethoxylate HLB 13). Coupling proceeds at 10–15 °C for 3 h, after which the pH is raised to 3.5–4.0 with sodium acetate. The precipitate is filtered, washed to neutral, and dried in an air oven at 80 °C. Minimum dye purity by diazo titration (DIN 55672-1) is ≥ 97%. High-temperature exhaust dyeing (HT process at 130 °C) on polyethylene terephthalate fabric yields build-up to 2/1 standard depth with 0.8–1.5% o.w.f. depending on the coupling partner. Fastness testing against ISO 105-B02 (xenon arc) shows lightfastness rating 6–7 for the chlorinated dyes, a gain of one full point compared to the non-halogenated analogue. Per Oeko-Tex Standard 100 Annex 4, the dye must not contain any detectable free aromatic amines originating from the coupling component (< 20 mg/kg, method DIN EN ISO 14362-1). The chlorothiazole carboxylate scaffold further permits conversion to fibre-reactive dyes by introducing a vinylsulfone or monochlorotriazine group onto the derived acid, a route exploited in limited-run inkjet printing inks that require REACH preregistration in the 1–10 t/a band.

    When This Intermediate Replaces 2-Aminothiazole in Succinate Dehydrogenase Inhibitor Lead Optimization

    Modern agrochemical R&D has evaluated 2-amino-5-chlorothiazole-4-carboxylic acid ethyl ester as a scaffold for conformationally restricted succinate dehydrogenase inhibitors (SDHIs) targeting the ubiquinone-binding pocket of mitochondrial complex II in phytopathogenic fungi. Unlike the simple 2-aminothiazole core, the 5-chloro substituent induces a dihedral twist of approximately 12° between the thiazole ring and the adjacent amide plane, as revealed by small-molecule X-ray crystallography, which improves fit into the hydrophobic cavity of *Botrytis cinerea* SDH. A discovery synthesis couples the chlorothiazole carboxylic acid (derived by saponification) with a substituted aniline using propanephosphonic acid anhydride (T3P, 1.5 eq) and diisopropylethylamine (3.0 eq) in ethyl acetate at 45 °C over 12 h. After aqueous work-up, the resulting thiazolecarboxamide intermediate is purified by silica gel chromatography (eluting with 25% acetone–hexane) and converted to the final SDHI candidate by further elaboration of the amine terminus. A representative compound tested at Syngenta’s Stein Research Centre against *Zymoseptoria tritici* gave an EC₅₀ of 0.08 mg/L in plate assays, with a protection window requiring ≤ 15 g a.i./ha in field trials. These still-confidential structures place the chlorothiazole ring at the ligand hinge region, where the chlorine forms a weak halogen bond with a carbonyl oxygen of the protein backbone (3.1 Å). Scale-up of the amide coupling from gram to kilogram quantity necessitates a process safety evaluation via adiabatic calorimetry (ASTM E1983) because of the potential for T3P self-decomposition above 105 °C. The recommended maximum temperature for the synthetic step (MTSR) is 80 °C with a cooling failure-adjusted phi factor below 1.1. For a substance intended for eventual regulatory submission under EC 1107/2009, the technical-grade active ingredient must contain the chlorothiazole-derived SDHI at ≥ 950 g/kg, with individual unknown impurities limited to ≤ 1.0 g/kg and the 2-amino-5-chlorothiazole-4-carboxylic acid residue controlled below 0.5 g/kg by HPLC-MS/MS. Ecotoxicological testing according to OECD 301 F indicates the free acid intermediate has a 28-day ready biodegradability of roughly 45%, classifying it as non- readily biodegradable and triggering PBT assessment under REACH Annex XIII. Consequently, any contract manufacturer handling this intermediate for agricultural R&D supply must operate a closed-loop waste stream with incineration at > 1100 °C and residence time exceeding 2 seconds to meet EU 2000/76/EC emission limits for organohalogens.
    Free Quote

    Competitive 4-Thiazolecarboxylicacid,2-Amino-5-Chloro-,Ethylester(9Ci) prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615651039172

    Email: sales9@bouling-chem.com

    Get Free Quote of Bouling Chemical Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Ethyl 2-amino-5-chlorothiazole-4-carboxylate, formally indexed as 4‑Thiazolecarboxylic acid, 2‑amino‑5‑chloro‑, ethyl ester (9CI), functions as a dense heterocyclic building block whose three reactive centres—the primary amine, the ring‑chlorine, and the ester carbonyl—open orthogonal derivatisation pathways without transient protection. The CAS registry number is recorded within the 9th Collective Index entry; the empirical formula is C6H7ClN2O2S, yielding a molecular mass of 206.65 g mol−1. Commercial material typically assays between 97.0 % and 99.5 % by HPLC (reverse‑phase C18, detection at 254 nm), with the balance largely composed of the corresponding carboxylic acid arising from partial ester hydrolysis. This document delineates the compound’s specification envelope, its process‑scale behaviour in cross‑coupling and acylation cascades, and key divergences from the 5‑bromo analogue and the methyl ester congener.

    Storage stability and packaging incompatibilities. Prolonged storage above −20 °C accelerates dimerisation via intermolecular aminolysis of the ester group, generating a non‑volatile amide dimer detectable by LC‑MS. Therefore, shipments employ vacuum‑sealed, amber‑glass vials under argon blanket. Polyethylene containers are avoided because leachable plasticisers catalyse ester cleavage when the material is stored above 5 °C for more than 72 h. When the headspace relative humidity exceeds 45 %, the powder should be pre‑dried in a vacuum oven at 35 °C for 4 h before engaging in moisture‑sensitive reactions such as Grignard additions or Buchwald‑Hartwig couplings.

    How Does the 5‑Chloro Substituent Alter Oxidative Addition Rates Versus the 5‑Bromo Analogue?

    Palladium‑catalysed Suzuki‑Miyaura cross‑coupling of the 5‑chloro derivative proceeds with a markedly slower oxidative addition step relative to 5‑bromo‑2‑aminothiazole‑4‑carboxylate esters. Kinetic profiling on a 100 mL EasyMax reactor with in‑situ ReactIR monitoring (Mettler Toledo) shows an induction period of 12‑18 min when using Pd(PPh3)4 (2 mol%) in anhydrous DME at 80 °C with K2CO3, compared to 5‑8 min for the bromo compound under identical conditions. This latency originates in the higher bond‑dissociation energy of the C–Cl bond and requires deliberate ligand selection: SPhos or XPhos precatalysts (e.g., RuPhos Pd G3) suppress catalyst deactivation and allow full conversion within 3 h for coupling with phenylboronic acid. Bulkier boronic esters, particularly those bearing ortho‑substituents, extend the cycle time to 8‑10 h, which on pilot‑plant scale ( 50 L glass‑lined reactor) introduces a thermal budget conflict: prolonged heating at 80 °C promotes concomitant ester hydrolysis, generating the free acid that sequesters palladium and causes emulsion formation during the final aqueous sodium‑bicarbonate wash. Published data for the specific activation energy of oxidative addition of this exact 5‑chlorothiazole ester on a ton‑scale run is limited; however, calorimetric data from a 1 kg demonstration batch suggest the adiabatic temperature rise remains below ΔTad = 12 K, well within safe operating limits for a class‑3 solvent system.

    Specification Profile and Release Criteria for Early‑Phase cGMP Intermediates

    Table 1 — Release specification aligned with ICH Q3A guidelines for small‑molecule intermediates.
    Parameter Methodology Acceptance Criterion
    Assay (anhydrous, solvent‑free basis) HPLC, C18 column, 0.1 % TFA in H2O/MeCN gradient, 254 nm 98.0 %102.0 %
    Related substances (total) Same HPLC system, integrated at 0.05 % threshold 1.5 % total; no single unknown ≥ 0.5 %
    Free acid (hydrolysis product) HPLC, relative retention time ~0.72 1.0 %
    Residual solvents — ethyl acetate Headspace GC‑FID, USP <467> 5000 ppm
    Residual solvents — dichloromethane Headspace GC‑FID, USP <467> 600 ppm
    Water content Karl Fischer coulometric, USP <921> 0.5 % w/w
    Melting range Differential scanning calorimetry, onset temperature, 10 K/min 149 °C153 °C
    Appearance Visual inspection against USP reference standard White to off‑white crystalline powder

    During qualification of an external manufacturing site, three consecutive batches exhibited an uncharacteristic pink discoloration traced to iron contamination at 2.3 ppm from a corroded stainless‑steel centrifuge. Subsequent installation of Hastelloy C‑276 wetted parts and a pre‑rinse with 0.01 M EDTA solution eliminated the excursion and restored a consistent melting point envelope of 150.1 °C ± 1.1 °C across 12 batches.

    When the Ethyl Ester Is Preferentially Selected Over the Methyl Ester in Multi‑Step Acylation Cascades

    Although the methyl ester congener (methyl 2‑amino‑5‑chlorothiazole‑4‑carboxylate) exhibits a 7‑10 % faster acylation rate with benzoyl chloride in dichloromethane/triethylamine at 0 °C, the ethyl ester offers a decisive advantage during aqueous quench of the subsequent step. In a typical sequence—coupling an acyl chloride to the 2‑amine followed by immediate lithium hydroxide‑mediated ester hydrolysis to release the carboxylic acid—the methyl ester’s methanol by‑product forms a persistent azeotrope with the tetrahydrofuran cosolvent, complicating solvent swap to toluene for the following amide bond formation. The ethanol liberated from the ethyl ester is readily removed by azeotropic distillation with heptane at 65 °C, leaving a crystalline sodium carboxylate that can be telescoped directly into a HATU‑mediated amidation without intermediate isolation. This operational simplicity reduces the unit operation count from 5 to 3 on kilogram scale, cutting overall cycle time by approximately 25 % per batch.

    In one development‑scale campaign targeting a clinical candidate, replacement of the methyl ester with the ethyl ester eliminated a persistent gelation problem during the coupling of a sterically hindered 2,6‑dimethylbenzoyl chloride. The gel, believed to arise from hydrogen‑bonding networks between the partially hydrolysed methyl ester and the triethylamine hydrochloride salt, did not form when the ethyl ester was used at identical stoichiometry (1.05 eq relative to amine). The reaction mixture remained freely stirrable in a 20 L HEL polyblock reactor, permitting a linear scale‑up from 200 g to 2.8 kg with an isolated yield of 84 % after a single isopropyl‑acetate recrystallisation.

    Comparison of Physicochemical and Reactivity Profiles Among Three Thiazole Esters

    Table 2 — Distinguishing attributes of the 5‑chloro ethyl ester, 5‑bromo ethyl ester, and 5‑chloro methyl ester.
    Property 5‑Cl Ethyl Ester 5‑Br Ethyl Ester 5‑Cl Methyl Ester
    Molecular weight 206.65 251.10 192.62
    Melting point (DSC onset) 150.1 °C 138.7 °C 161.3 °C
    Solubility in THF at 25 °C 18.2 g/100 mL 21.5 g/100 mL 14.8 g/100 mL
    Relative Suzuki coupling rate (krel) 0.18 (RuPhos Pd G3) 1.0 (reference) 0.22
    Ease of ester hydrolysis to acid LiOH, THF/H2O, 2 h at rt LiOH, 1.5 h at rt LiOH, 1.5 h at rt; faster but methanol removal complicates work‑up
    Typical application Late‑stage diversification of antimicrobial leads Rapid exploratory library synthesis Cost‑sensitive campaigns where solvent‑swap not required

    The bromo derivative’s higher mass and faster cross‑coupling are offset by its susceptibility to photolytic de‑bromination under standard laboratory fluorescent lighting; a 12 h exposure resulted in 3.2 % debromination in a batch stored in clear glass, whereas the chloro compound showed no detectable dehalogenation after 72 h under identical illuminance.

    Purification bottlenecks during vacuum distillation. Attempts to purify the crude ethyl ester by short‑path distillation revealed a narrow thermal processing window. At 0.5 mbar the ester distilled at a pot temperature of 135‑140 °C, but residence times exceeding 15 min caused partial decomposition with evolution of HCl gas, which accelerated corrosion of the glass apparatus and promoted further ester cleavage. Installation of a wiped‑film evaporator (Pope Scientific, 0.05 m2 surface area) with a feed rate of 80 g/min and jacket temperature of 130 °C achieved continuous purification of 5 kg in 62 min with a purity uplift from 94.1 % to 99.1 % and a distillation yield of 92 %. The thin‑film configuration limited the hot zone residence time to under 20 s, suppressing thermal degradation. Scale‑up to a 0.5 m2 unit would require careful calculation of the allowable vapour velocity to avoid entrainment, but published data for this specific ester on a 0.5 m2 wiped‑film evaporator is limited.

    Diazotisation‑Sandmeyer sequence with retention of the ester function. The aromatic primary amine undergoes smooth diazotisation with sodium nitrite in concentrated phosphoric acid at −10 °C to −5 °C. Subsequent chlorination (Sandmeyer) or bromination yields the 2,5‑dihalo ester without nucleophilic displacement of the 5‑chloro substituent. Crucially, the ethyl ester survives this strongly acidic aqueous environment with less than 0.3 % hydrolysis if the temperature is maintained below −5 °C and the total acid concentration does not fall below 85 %. This contrasts with the methyl ester, where methoxy protonation under the same conditions results in 1.5‑2.0 % methyl ester hydrolysis, forming the acid and leading to a difficult‑to‑remove impurity that co‑crystallises with the target dihalo product in isopropanol.

    Catalytic hydrogenation and amine poisoning risks. Reductive dechlorination on Pd/C (10 % w/w, dry basis) in ethanol proceeds readily at 1 bar H2, but the liberated chloride anion poisons the catalyst surface, causing a gradual drop in activity after 3‑4 recycles. Doping the catalyst with 0.5 % w/w copper (as Cu2O) extends the recyclability to 8 cycles, according to a technical bulletin from a major catalyst manufacturer, though the copper‑doped catalyst introduces a tolerance limit of ≤ 2 ppm residual copper in the active pharmaceutical ingredient, necessitating a chelating resin polish.

    Regulatory status and supply chain classification. The compound is not listed as a controlled substance under REACH, and it is routinely shipped as a non‑hazardous item under UN3077 (environmentally hazardous solid, n.o.s.) when classified for transport. For use in a drug substance, a supplier qualification audit verifying ICH Q7 compliance for raw materials should confirm that the reductive amination step that often follows does not carry over genotoxic impurities from the thiazole building block. Purge factor studies in a spiked model system, measured by LC‑MS/MS at a limit of quantification of 0.5 ppm, indicate that the ester and its des‑chloro analogue purge to below the threshold of toxicological concern (1.5 μg/day) after a single crystallisation from ethyl acetate/heptane.